1. Home
  2. CLPS vs FEMY Comparison

CLPS vs FEMY Comparison

Compare CLPS & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLPS
  • FEMY
  • Stock Information
  • Founded
  • CLPS 2005
  • FEMY 2004
  • Country
  • CLPS Hong Kong
  • FEMY United States
  • Employees
  • CLPS N/A
  • FEMY N/A
  • Industry
  • CLPS Computer Software: Prepackaged Software
  • FEMY Medical/Dental Instruments
  • Sector
  • CLPS Technology
  • FEMY Health Care
  • Exchange
  • CLPS Nasdaq
  • FEMY Nasdaq
  • Market Cap
  • CLPS 26.9M
  • FEMY 29.9M
  • IPO Year
  • CLPS 2018
  • FEMY 2021
  • Fundamental
  • Price
  • CLPS $0.92
  • FEMY $0.84
  • Analyst Decision
  • CLPS
  • FEMY Strong Buy
  • Analyst Count
  • CLPS 0
  • FEMY 3
  • Target Price
  • CLPS N/A
  • FEMY $8.67
  • AVG Volume (30 Days)
  • CLPS 11.0K
  • FEMY 158.0K
  • Earning Date
  • CLPS 03-05-2025
  • FEMY 08-07-2025
  • Dividend Yield
  • CLPS 13.71%
  • FEMY N/A
  • EPS Growth
  • CLPS N/A
  • FEMY N/A
  • EPS
  • CLPS N/A
  • FEMY N/A
  • Revenue
  • CLPS $153,816,045.00
  • FEMY $1,699,232.00
  • Revenue This Year
  • CLPS N/A
  • FEMY $283.83
  • Revenue Next Year
  • CLPS N/A
  • FEMY $161.03
  • P/E Ratio
  • CLPS N/A
  • FEMY N/A
  • Revenue Growth
  • CLPS 5.81
  • FEMY 61.97
  • 52 Week Low
  • CLPS $0.68
  • FEMY $0.69
  • 52 Week High
  • CLPS $1.70
  • FEMY $1.80
  • Technical
  • Relative Strength Index (RSI)
  • CLPS 42.16
  • FEMY 37.62
  • Support Level
  • CLPS $0.92
  • FEMY $0.91
  • Resistance Level
  • CLPS $1.00
  • FEMY $0.93
  • Average True Range (ATR)
  • CLPS 0.05
  • FEMY 0.04
  • MACD
  • CLPS -0.00
  • FEMY -0.01
  • Stochastic Oscillator
  • CLPS 15.32
  • FEMY 5.12

About CLPS CLPS Incorporation

CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: